Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
H
Hachey, Stephanie
University of California, Irvine
P50: Novel Vascularized Microtumor (VMT) Model of Peritoneal Carcinomatosis (PC) with Mesothelial-Lined Chambers and Submesothelial Stroma that Mimic the Peritoneal Cavity
Location:SSO HUB: Rare/Metastatic Cancers Zone
Stephanie Hachey
Haffty, Bruce
Rutgers Cancer Institute of New Jersey
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)
Location:Veterans Memorial Auditorium
Bruce Haffty
Hahn, Olwen
University of Chicago
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)
Location:Veterans Memorial Auditorium
Olwen Hahn
Hakki, Lynn
Memorial Sloan Kettering Cancer Center
P20: Microsatellite Instability (MSI): The Transition from Favorable to Unfavorable Outcomes with Lymph Node Metastases
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Lynn Hakki
Halfdanarson, Thorvardur
Medical Oncology
P31: Accuracy of DOTATATE PET/CT in the Preoperative Planning of Small Bowel Neuroendocrine Tumor Resection
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Thorvardur Halfdanarson
Halfteck, Gili
University of Texas Medical Branch
8: De-escalation of Post-Mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes
Location:Veterans Memorial Auditorium
Gili Halfteck
Hallet, Julie
University of Toronto; Odette Cancer Centre - Sunnybrook Health Sciences Centre
84: The association between familiarity of the surgeon-anesthesiologist dyad and post-operative patient outcomes for complex gastrointestinal cancer surgery: a population-based study.
Location:Ballroom B
Julie Hallet
Assessment and Management of Older Adults for HPB Cancer Surgery
Location:SSO HUB Theater
Julie Hallet
P16: The role of anastomotic leak as a potential high-risk criteria in Stage II colon cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Julie Hallet
Hall, William
Medical College of Wisconsin
48: Machine Learning Derived Electronic Tumor Marker Mimics Prognostic Properties of CA19-9
Location:Ballroom A
William Hall
Halperin, Daniel
University of Texas MD Anderson Cancer Center
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors
Location:Ballroom A
Daniel Halperin
Hamed, Ahmed
University of Pittsburgh
73: Predicting Early Recurrence to optimize Patient Selection for Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy in High-Grade Appendiceal Mucinous Carcinoma Peritonei
Location:Ballroom B
Ahmed Hamed
P52: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
Location:SSO HUB: Rare/Metastatic Cancers Zone
Ahmed Hamed
Hammer, Suntrea
University of Texas Southwestern Medical Center
96: Serum IL-6 level predicts survival and treatment response in gastric and gastroesophageal junction cancer
Location:Ballroom A
Suntrea Hammer
Hammill, Chet
Washington University School of Medicine
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Chet Hammill
Hammons, Jacklyn
Emory University
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Jacklyn Hammons
Handorf, Elizabeth
Division of Biostatistics and Bioinformatics, Fox Chase Cancer Center, Philadelphia, USA
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Elizabeth Handorf
Hanes, Douglas
Providence Health and Services
P47: Predicting recurrence after a negative sentinel lymph node in melanoma: the model changes with time and sites of recurrence
Location:SSO HUB: Melanoma & Sarcoma Zone
Douglas Hanes
Hanna, David
Vanderbilt University Medical Center
23: Single-cell RNA Sequencing Reveals Distinct Populations of Tumor Associated Macrophages in Colorectal Metastasis.
Location:Ballroom C
David Hanna
Hannah, Cathleen
National Institutes of Health, National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Cathleen Hannah
Hanna, Nader
University of Maryland School of Medicine
Non-Operative Management of Rectal Cancer
Location:Ballroom B
Nader Hanna
Haque, Waqar
University of Texas medical Branch
8: De-escalation of Post-Mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes
Location:Veterans Memorial Auditorium
Waqar Haque
Harding, James
Memorial Sloan Kettering Cancer Center
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
James Harding
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
James Harding
Hari, Parameswaran
Iovance Biotherapeutics, Inc., San Carlos, CA, USA
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Parameswaran Hari
Harrington, Kevin
Royal Marsden NHS Foundation Trust, The Institute of Cancer Research
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Kevin Harrington
Harrington, Michael
USF Morsani College of Medicine, Tampa, FL, USA
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
Michael Harrington
Harris, Chris
University of Rochester
50: Anti-Netrin-1 Therapy Inhibits Metastasis and Improves Survival in Pancreatic Cancer
Location:Ballroom A
Chris Harris
Hatch, Sandra
University of Texas Medical Branch
8: De-escalation of Post-Mastectomy Irradiation in Hormone Receptor-Positive Breast Cancer with One to Three Positive Nodes
Location:Veterans Memorial Auditorium
Sandra Hatch
Hawkins, Alexander
Vanderbilt University Medical Center
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Alexander Hawkins
Hayes, Andrew
Royal Marsden Hospital
P62: Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Andrew Hayes
Haynes, Alex
The University of Texas at Austin Dell Medical School
The Evolution of Novel Combination Immunotherapies – Intralesional Treatments and New Targets for Treatment
Location:SSO HUB: Immuno-Oncology Zone
Alex Haynes
Hayoz, Stefanie
SAKK Coordinating Center, Bern, Switzerland
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Stefanie Hayoz
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Stefanie Hayoz
Heaton, Martin
Norfolk & Norwich University Hospital Foundation NHS Trust
59: Validating the Use of Surrogate Endpoints to Assess the Survival Outcomes of Melanoma Patients in Clinical Trials
Location:Veterans Memorial Auditorium
Martin Heaton
62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma
Location:Veterans Memorial Auditorium
Martin Heaton
Heil, Jörg
Breast Center Heidelberg, Heidelberg, Germany
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Jörg Heil
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Jörg Heil
He, Jin
Johns Hopkins University School of Medicine
Upper GI Parallel Session
Location:Ballroom A
Jin He
Upper GI Poster Presentations 2
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Jin He
Hendifar, Andrew
Cedars-Sinai Medical Center - Los Angeles, CA
32: Impact of Primary Tumor Resection on Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Location:Ballroom A
Andrew Hendifar
Hendren, Samantha
University of Michigan
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Samantha Hendren
Hendrick, Leah
The University of Tennessee Health Science Center
P27: Follicular Thyroid Carcinoma with Nodal Metastases: A National Study
Location:SSO HUB: Breast & Endocrine Zone
Leah Hendrick
Henke, Guido
Department of Radiation Oncology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland; Breast Center, St. Gallen Cantonal Hospital, St. Gallen, Switzerland
12: Impact of imaging-guided localization on performance of tailored axillary surgery in patients with clinically node-positive breast cancer: Prospective study within TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Guido Henke
17: Axillary dissection to determine nodal burden to inform systemic therapy recommendations for clinically node-positive breast cancer: Pre-planned substudy of TAXIS (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101)
Location:Veterans Memorial Auditorium
Guido Henke
Henriquez, Andres
Department of Endocrinology, Mayo Clinic
P28: Hurthle cell carcinoma - Is a hemithyroidectomy enough?
Location:SSO HUB: Breast & Endocrine Zone
Andres Henriquez
Herbert, Garth
Duke University
P33: Personalized Circulating Tumor DNA and Survival in Patients with Resectable Pancreatic Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Garth Herbert
Hernandez-Alejandro, Roberto
University of Rochester Medical Center
38: Semaphorin 4D is Expressed by Activated Lymphocytes in Pancreatic Adenocarcinoma, and Monoclonal Blockade Sensitizes Murine Tumors to Immune Checkpoint Therapy
Location:Ballroom B
Roberto Hernandez-Alejandro
46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma
Location:Ballroom A
Roberto Hernandez-Alejandro
Hernandez, Jonathan
National Institutes of Health
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Jonathan Hernandez
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Location:SSO HUB: Rare/Metastatic Cancers Zone
Jonathan Hernandez
Hernandez, Matthew
City of Hope
P35: Slow Adoption of Observation for Small Pancreatic Neuroendocrine Tumors
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Matthew Hernandez
Hernandez, Sharia
MD Anderson Cancer Center
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors
Location:Ballroom A
Sharia Hernandez
Herre, Margaret
Weill Cornell Medical College
P17: Trends in the Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Margaret Herre
Herrera-Almario, Gabriel
Fundación Santa Fe de Bogotá
102: Robotic-assisted minimally invasive radical total gastrectomy with intracorporeal side-to-side esophagojejunostomy
Location:Veterans Memorial Auditorium
Gabriel Herrera-Almario
Hezel, Aram
University of Rochester Medical Center
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Aram Hezel
Hieken, Tina
Mayo Clinic
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Tina Hieken
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Tina Hieken
P75: “Next Gen” Operative Notes – synoptic operative reporting for cancer surgery
Location:SSO HUB: Rare/Metastatic Cancers Zone
Tina Hieken
Hiotis, Spiros
Icahn School of Medicine at Mount Sinai
P80: Accuracy of Clinical Staging for Intramural (T2) Gastric Cancer: Survival Outcomes Following Upfront Surgical Resection Compared to Risk of Overtreatment with Neoadjuvant Therapy
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Spiros Hiotis
Hirata, Yuki
MD Anderson Cancer Center
100: Robotic Subtotal Gastrectomy with D2 Lymph Node Dissection using Indocyanine Green Sentinel Lymphatic Mapping
Location:Veterans Memorial Auditorium
Yuki Hirata
Hlaing, May Zin
Division of Colon and Rectal Surgery, Department of Surgery, The Ohio State Wexner Medical Center
P13: Multiomic Profile of Colorectal Cancer Cell Line Radiosensitivity
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
May Zin Hlaing
Hnin, Su
SUNY Downstate Medical School
P73: How much does postoperative pain interfere with activities of daily living after breast surgery?
Location:SSO HUB: Rare/Metastatic Cancers Zone
Su Hnin
Hoehn, Richard
University Hospitals, Cleveland Medical Center
31: Factors Predicting Immunotherapy Utilization for Metastatic Merkel Cell Carcinoma from 2015-2018
Location:Ballroom A
Richard Hoehn
98: Disparities in Receipt of Complex GI Cancer Surgery at a Small Geographic Scale
Location:Ballroom A
Richard Hoehn
P26: Applying 8th edition AJCC guidelines to differentiated thyroid cancer: Stage migration and impact on overall survival
Location:SSO HUB: Breast & Endocrine Zone
Richard Hoehn
P69: Understanding Factors Leading to Surgical Attrition for “Resectable” Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Richard Hoehn
Hoeller, Christoph
Medizinische Universität Wien
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Christoph Hoeller
Hoffe, Sarah
Moffitt Cancer Center
97: Long-term Oncologic Outcomes Following Pathologic Complete Response (pCR) for Esophageal Cancer
Location:Ballroom A
Sarah Hoffe
Hoffman, Robert
AntiCancer Inc.
P83: Primary and Metastatic Gastric Cancers in Patient-derived Orthotopic Xenografts Brightly Labeled by Fluorescent anti-CEA Antibody
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Robert Hoffman
Hogg, Melissa
NorthShore
Panel: Pursuing a Career in Academia Versus Private Practice
Location:Room 302
Melissa Hogg
Holder, Ashley
UT MD Anderson Cancer Center
High Risk SCCA - Should Anyone get SLNB? CLND?
Location:SSO HUB: Melanoma & Sarcoma Zone
Ashley Holder
Holder-Murray, Jennifer
University of Pittsburgh Medical Center
26: Neoadjuvant Chemoradiation Does Not Improve Outcomes for Patients Undergoing Resection for Upper Rectal Cancer: A US Rectal Cancer Consortium Analysis
Location:Ballroom C
Jennifer Holder-Murray
Holtzman, Matthew
University of Pittsburgh Medical Center
73: Predicting Early Recurrence to optimize Patient Selection for Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy in High-Grade Appendiceal Mucinous Carcinoma Peritonei
Location:Ballroom B
Matthew Holtzman
P52: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
Location:SSO HUB: Rare/Metastatic Cancers Zone
Matthew Holtzman
Hompes, Daphne
Department of Surgical Oncology, University Hospitals Leuven, Leuven, Belgium
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Daphne Hompes
Hong, Young
Cooper University Hospital
10: Epigenetic Drug Therapy Increases Immune Activation and Expression of Genes in the Oncotype Dx Score in Breast Cancer
Location:Veterans Memorial Auditorium
Young Hong
Hoon, Dave
St John's Cancer Institute
61: Smoking imparts shorter disease specific survival in patients with primary cutaneous melanoma
Location:Veterans Memorial Auditorium
Dave Hoon
Hopkins, Brent
McGill University
P12: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast Conserving Surgery After Neoadjuvant Chemotherapy
Location:SSO HUB: Breast & Endocrine Zone
Brent Hopkins
Hoskin, Tanya
Mayo Clinic Rochester
P4: Clinical Behavior, Management and Treatment Response of Estrogen Receptor Low (1-10%) Breast Cancer by PR expression
Location:SSO HUB: Breast & Endocrine Zone
Tanya Hoskin
Hougaard Chakera, Annette
Department of Plastic Surgery, Herlev University Hospital, Denmark
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Annette Hougaard Chakera
Hou, Jeannie
Replimune Inc.
60: Safety, efficacy, and biomarker assessment of RP1 in combination with nivolumab in patients with advanced skin cancers
Location:Veterans Memorial Auditorium
Jeannie Hou
Howell, Thomas
Duke University Medical Center
P60: Evolution in management of upfront treatment for desmoid tumors
Location:SSO HUB: Melanoma & Sarcoma Zone
Thomas Howell
P79: Impact of Tumor Size and Management on Survival in Gastric GIST
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Thomas Howell
Huang, Hai
The Feinstein Institutes
P57: Phosphorylation of IWS1 by AKT Maintains Liposarcoma Tumor Heterogeneity through Preservation of Cancer Stem Cell Phenotypes and Mesenchymal-Epithelial Plasticity
Location:SSO HUB: Melanoma & Sarcoma Zone
Hai Huang
Huang, Huocong
UT Southwestern Medical Center, Dept of Surgery
49: Stroma Selective Inhibition of TGFβ – Genomic Stratification As The Key to Overcoming Failed Clinical Translation in Pancreatic Cancer
Location:Ballroom A
Huocong Huang
Huang, Reiping
Northwestern University
P70: A call for more equitable care in colon cancer: The association between racial and socioeconomic disparities and hospital quality
Location:SSO HUB: Rare/Metastatic Cancers Zone
Reiping Huang
Huang, Rong
University of California Los Angeles
P43: Prognostic assessment of sentinel lymph node metastases: Are we using the wrong measure of tumor burden?
Location:SSO HUB: Melanoma & Sarcoma Zone
Rong Huang
Hubbard, Rebecca
Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania
P67: Neighborhood Deprivation and Breast Cancer Outcomes in Philadelphia
Location:SSO HUB: Rare/Metastatic Cancers Zone
Rebecca Hubbard
Hudgens, Courtney
MD Anderson Cancer Center
95: Cancer Testis Antigen and Interleukin Expression Correlates with Survival in Small Bowel Neuroendocrine Tumors
Location:Ballroom A
Courtney Hudgens
Hughes, Christopher
UC Irvine
P50: Novel Vascularized Microtumor (VMT) Model of Peritoneal Carcinomatosis (PC) with Mesothelial-Lined Chambers and Submesothelial Stroma that Mimic the Peritoneal Cavity
Location:SSO HUB: Rare/Metastatic Cancers Zone
Christopher Hughes
Hughes, Tasha
University of Michigan
Value Based Cancer Care: Where Are We Now?
Location:Ballroom A
Tasha Hughes
Hu-Lieskovan, Siwen
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
Siwen Hu-Lieskovan
Hunt, Kelly
The University of Texas MD Anderson Cancer Center
1: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance)
Location:Veterans Memorial Auditorium
Kelly Hunt
5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
Location:Veterans Memorial Auditorium
Kelly Hunt
Lumicell Industry Spotlight Session: Intraoperative Imaging Inside the Breast Cavity for Real Time Margin Assessment and Residual Cancer Removal
Location:SSO HUB Theater
Kelly Hunt
P75: “Next Gen” Operative Notes – synoptic operative reporting for cancer surgery
Location:SSO HUB: Rare/Metastatic Cancers Zone
Kelly Hunt
Plenary Session 2
Location:Veterans Memorial Auditorium
Kelly Hunt
Hur, Dong
Stanford University School of Medicine
78: Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas
Location:Ballroom A
Dong Hur
Hu, Yinin
University of Maryland School of Medicine
Management of Medullary Thyroid Cancer in the Era of Targeted Therapy
Location:SSO HUB Theater
Yinin Hu
Huynh, Victoria
University of Colorado School of Medicine, Department of Surgery
P9: Comparing Patient Reported Outcomes for Same-day Discharge and Inpatient Admission After Mastectomy
Location:SSO HUB: Breast & Endocrine Zone
Victoria Huynh
Hu, Yue-Yang
Northwestern University Feinberg School of Medicine
P70: A call for more equitable care in colon cancer: The association between racial and socioeconomic disparities and hospital quality
Location:SSO HUB: Rare/Metastatic Cancers Zone
Yue-Yang Hu
Hwang, Rosa
The University of Texas MD Anderson Cancer Center
5: Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
Location:Veterans Memorial Auditorium
Rosa Hwang
Hwang, Shelley
Duke University
4: Germline Genetic Mutations in a Prospective Multi-Center Cohort of 241 Phyllodes Tumors; Time to Expand Testing Criteria
Location:Veterans Memorial Auditorium
Shelley Hwang
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
Shelley Hwang
R Type Grants (Approach, budgeting, special sections-VA, human subjects protection)
Location:Room 304
Shelley Hwang
Hyer, Madison
The Ohio State University Wexner Medical Center- Center for Biostatistics
P59: Comparing complete compartmental resection with tumor only resection of retroperitoneal soft tissue sarcoma using the win ratio
Location:SSO HUB: Melanoma & Sarcoma Zone
Madison Hyer
Hyngstrom, John
Huntsman Cancer Institute, University of Utah Health
53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma
Location:Veterans Memorial Auditorium
John Hyngstrom
57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations
Location:Veterans Memorial Auditorium
John Hyngstrom
Hyslop, terry
Jefferson Sidney Kimmel Cancer Center
P6: Short-term outcomes in DCIS patients managed without initial surgery
Location:SSO HUB: Breast & Endocrine Zone
terry Hyslop
Back to Top
